register

Human Resources

AbbVie appoints new HR Director with diverse expertise across healthcare

Health Industry Hub | April 17, 2024 |

AbbVie has appointed a new Human Resources Director for Australia and New Zealand. Ally Jonas assumed the role earlier this month and is reporting to Katy Olivera, Head of Business Human Resources for the Intercontinental Region.

Nathalie McNeil, VP and General Manager of AbbVie ANZ, expressed her enthusiasm for Ally’s appointment stating, “I’m thrilled to welcome Ally to the AbbVie ANZ team. Her leadership, strategic agility, people orientation and drive for always raising the bar is the perfect fit for the next chapter of our
organisation.”

Ally joins AbbVie following a long career in the healthcare and pharmaceutical industry. Ally’s
most recent role was at Reckitt Benckiser for 5 years where she held the role of HR Director, ANZ where she delivered “countless initiatives we deployed across the ANZ business which resulted in driving down employee turnover, increasing employee engagement, and truly bringing the meaning of ‘Care’ into our business.” Ally has also held senior leadership roles at Pfizer, Johnson and Johnson and Baxter Healthcare.

Reflecting on her decision to join AbbVie, Ally remarked “AbbVie’s reputation as a company with an incredible culture has always been an envy of the industry. To achieve and be recognised as a Great Place to Work ten years in a row is no mean feat.”

AbbVie also secured a coveted spot on the Great Places to Work Best Workplaces for Women List for 2023.

“Being recognised as one of the best workplaces for women is not just an award; it’s a validation of our commitment to creating an inclusive and empowering environment for all our employees,” Ms McNeil said on the company’s recognition.

“I’m excited to be part of a company that is deeply committed to its people,” Ally added.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


Medical

NSW Health to settle class action

NSW Health to settle ‘largest’ class action

Health Industry Hub | April 29, 2024 |

A class action alleging NSW Health underpaid clinicians has settled after the department agreed to a payout of nearly a […]

More


News & Trends - Pharmaceuticals

Lilly's first-in-class therapy PBS listed for early breast cancer after 15-year gap

Lilly’s first-in-class therapy PBS listed for early breast cancer after 15-year gap

Health Industry Hub | April 29, 2024 |

Pharma News: Australians diagnosed with early-stage breast cancer, particularly those at high risk of recurrence, will gain access to the […]

More


News & Trends - Pharmaceuticals

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

AstraZeneza secures four PBAC nods in oncology, diabetes, kidney and rare diseases

Health Industry Hub | April 29, 2024 |

Pharma News: AstraZeneca has scored four positive Pharmaceutical Benefits Advisory Committee (PBAC) recommendations following the March meeting. These recommendations, spanning […]

More


News & Trends - Pharmaceuticals

PBAC recommendation to reshape prescribing in heart failure

PBAC recommendation to reshape prescribing in heart failure

Health Industry Hub | April 29, 2024 |

Pharma News: Aligned with the government’s Scope of Practice Review, the Pharmaceutical Benefits Advisory Committee (PBAC) has made a practice-changing […]

More


This content is copyright protected. Please subscribe to gain access.